Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-05-29
2007-05-29
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C558S422000
Reexamination Certificate
active
10483163
ABSTRACT:
There are provided novel compounds of formula (I), wherein R1, R2, R3, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain
REFERENCES:
patent: 4296126 (1981-10-01), Nedelec et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4666910 (1987-05-01), Schneider et al.
patent: 4902710 (1990-02-01), Foster et al.
patent: 6743939 (2004-06-01), Birkinshaw et al.
patent: 2003/0139350 (2003-07-01), Larsen et al.
patent: 29 07 217 (1979-08-01), None
patent: 0 273 658 (1988-07-01), None
patent: 0 318 727 (1989-06-01), None
patent: 0 399 504 (1990-05-01), None
patent: 0 515 240 (1992-04-01), None
patent: 0 571 685 (1992-05-01), None
patent: 0 576 766 (1994-01-01), None
patent: 0 661 266 (1994-12-01), None
patent: 0 707 007 (1996-04-01), None
patent: 765849 (1957-01-01), None
patent: 922600 (1963-04-01), None
patent: 1014348 (1965-12-01), None
patent: 2 060 620 (1981-05-01), None
patent: 2 060 621 (1981-05-01), None
patent: 2060622 (1981-05-01), None
patent: 765849 (1995-01-01), None
patent: 51044934 (1976-12-01), None
patent: 52-941 (1977-01-01), None
patent: 52000941 (1977-01-01), None
patent: WO 92/19210 (1992-11-01), None
patent: WO 99/10339 (1999-03-01), None
patent: WO 99/11620 (1999-03-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 99/62883 (1999-12-01), None
patent: WO 00/27842 (2000-05-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO 01/62704 (2001-08-01), None
patent: WO 01/62714 (2001-08-01), None
patent: WO 01/62721 (2001-08-01), None
patent: WO 02/20484 (2002-03-01), None
patent: WO 02/30899 (2002-04-01), None
patent: WO 02/090332 (2002-11-01), None
patent: WO 03/011830 (2003-02-01), None
Chemical Abstracts, CAPLUS accession No. 1998: 394854 (Zhongguo Yaoke Daxue Xuebao, 1998, 29, 81-91).
Chemical Abstracts, CAPLUS accession No. 1968: 28182 (J. Med. Chem., 1968, 11, 95-97).
Chemical Abstracts, CAPLUS accession No. 1997: 534782 (Zhongguo Yaoke Huaxue Zazhi, 1997, 7, 1-8).
Chemical Abstracts, CAPLUS accession No. 1999: 659361 (WO 99/51575).
Chemical Abstracts, CAPLUS accession No. 1967: 499505 (J. Chem. Soc. B, 1967, 859-866).
Chemical Abstracts, CAPLUS accession No. 1994: 579176 (Tetrahedron Letters, 1994, 35, 4585-4586).
Chemical Abstracts, CAPLUS accession No. 1968: 29366 (Probl. Poluch, Poluprod. Prom. Org. Sin., 1967, 90-97).
Chemical Abstracts, CAPLUS accession No. 1995: 664999 (DE 4 331 179).
Chemical Abstracts, CAPLUS accession No. 1995: 913361 (WO 95/15954).
Chemical Abstracts, CAPLUS accession No. 1981: 121503 (DE 2 905 877).
Chemical Abstracts, CAPLUS accession No. 1990: 35674 (JP A2 01168666).
Chemical Abstracts, CAPLUS accession No. 1978: 169760 (JP A2 52153922).
Chemical Abstracts, CAPLUS accession No. 1977: 189458 (JP B4 51044934).
Chemical Abstracts, CAPLUS accession No. 1996: 113480 (SU 1824396).
Chemical Abstracts, 1965, vol. 62, 16781 (J. Med. Chem. 1965, 8, 356-367).
Chemical Abstracts, 1958, vol. 52, 11069 (J. Am. Chem. Soc., 1958, 80, 162-164).
Chemical Abstracts, 1966, vol. 65, 2181 (Neth. Appln. 6,508,754).
Yan et al., “Potential casual prophylactic antimalarial agents. Synthesis of quinoxaline, benzimidazole, and alkoxybenzene derivatives containing a novoldiamine moiety”,J. Heterocycl. Chem.297-300 (1978).
Cheshire David
Connolly Stephen
Mete Antonio
AstraZeneca AB
Fish & Richardson P.C.
Sackey Ebenezer
Wilson James O.
LandOfFree
Arylheteroalkylamine derivatives and their use as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylheteroalkylamine derivatives and their use as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylheteroalkylamine derivatives and their use as inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3761834